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Background: The aim of this study was to investigate the effect of various classes of clinically relevant antibiotics at
sub-lethal concentrations on virulence gene expression and biofilm formation in Staphylococcus aureus.
Findings: LacZ promoter fusions of genes related to staphylococcal virulence were used to monitor the effects of
antibiotics on gene expression in a disc diffusion assay. The selected genes were hla and spa encoding α-hemolysin
and Protein A, respectively and RNAIII, the effector molecule of the agr quorum sensing system. The results were
confirmed by quantitative real-time PCR. Additionally, we monitored the effect of subinhibitory concentrations of
antibiotics on the ability of S. aureus to form biofilm in a microtiter plate assay. The results show that sub-lethal
antibiotic concentrations diversely modulate expression of RNAIII, hla and spa. Consistently, expression of all
three genes were repressed by aminoglycosides and induced by fluoroquinolones and penicillins. In contrast, the
β-lactam sub-group cephalosporins enhanced expression of RNAIII and hla but diversely affected expression of spa.
The compounds cefalotin, cefamandole, cefoxitin, ceftazidime and cefixine were found to up-regulate spa, while
down-regulation was observed for cefuroxime, cefotaxime and cefepime. Interestingly, biofilm assays demonstrated
that the spa-inducing cefalotin resulted in less biofilm formation compared to the spa-repressing cefotaxime.
Conclusions: We find that independently of the cephalosporin generation, cephalosporins oppositely regulate spa
expression and biofilm formation. Repression of spa expression correlates with the presence of a distinct
methyloxime group while induction correlates with an acidic substituted oxime group. As cephalosporines target
the cell wall penicillin binding proteins we speculate that subtle differences in this interaction fine-tunes spa
expression independently of agr.
Keywords: Staphylococcus aureus, Subinhibitory concentrations, Antibiotics, Virulence, Protein A (spa), Biofilm
formationFindings
Background
Small molecules, such as antibiotics, are ubiquitous in
the environment whether they originate directly from
producing microorganisms or are the waste products of
human activities [1,2]. While the antimicrobial activity
of antibiotics target basic cellular functions like DNA,
protein or cell wall synthesis they also affect other
processes such as virulence gene expression [3,4]. β-
lactam-containing penicillins and cephalosporins target
transpeptidase and transglycosylase domains of the bac-
teria. They act as pseudosubstrates and acylate the active
sites of the transpeptidases (also termed penicillin-* Correspondence: hi@life.ku.dk
Department of Veterinary Disease Biology, University of Copenhagen,
Copenhagen, Denmark
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reproduction in any medium, provided the orbinding proteins or PBPs) and have been widely used for
treating infections including S. aureus [5].
S. aureus is a serious human pathogen that causes
many different types of illnesses ranging from entero-
toxin mediated food intoxications to more severe infec-
tions such as endocarditis, pneumonia, osteomyelitis and
toxic shock [6]. The pathogen is also one of the leading
causes of biofilm-associated infections that typically are
chronic and frequently occur in hospitals [7]. One of the
key virulence factors often studied is α-hemolysin
encoded by hla. α-hemolysin is a pore-forming toxin
that targets red and white blood cells among other cell
types [8,9]. While toxins and degradation enzymes are
produced in stationary phase, the surface located viru-
lence factors, including the IgG binding Protein A
encoded by spa, are expressed in exponential phase.Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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Figure 1 Representative results of disc diffusion assay
monitoring transcriptional effects of cephalosporins.
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known to be involved in development of pneumonia
[10,11]. The protein has been proposed to act together
with the Panton-Valentine leukocidin (PVL) to cause the
severe inflammation and tissue damage seen in necrotiz-
ing pneumonia [12]. The agr quorum sensing system is
the main regulator of virulence in S. aureus and controls
the expression of at least 70 genes [13-15]. The effector
molecule RNAIII inversely regulates hla (up) and spa
(down) in response to increasing cell density [16].
The multitude of virulence factors contributing to the
pathogenesis of S. aureus have spurred interest in how
sub-lethal concentrations of antibiotics affect their ex-
pression and possibly modulate the outcome of infec-
tion. Exposure to macrolides, aminoglycosides and
clindamycin reduces hla expression [17,18] whereas
β-lactams and fluoquinolones increase transcription
of hla [4]. The β-lactams have been used widely to treat
S. aureus infections and here penicillins, cephalosporins
and the carbapenem imipenem all increased hla expres-
sion with the monobactam aztreonam being the only ex-
ception [4]. For the cephalosporines this stimulation is
likely to involve the SaeRS two-component system as the
haemolytic activity induced by cefoxitin was abolished in
the absence of saeRS [19]. However, a microarray gene ex-
pression analysis revealed that additional factors might be
involved in the activation of hla expression by the ceph-
alosporin cefoxitin [19]. spa transcription was examined
in response to cell wall active antibiotics, including peni-
cillins, cephalosoprins, carbanems and glycopeptides [20].
Induction levels varied between closely related antibiotics
and the authors proposed that a chlorine substitution or
cephalosporin generation could be responsible for the op-
posite effect of various penicillins on spa expression [20].
Although only addressed in a few cases, it appears that
several unrelated types of antibiotics commonly either en-
hance or reduce expression of all the tested virulence
genes no matter whether they encode cell surface or the
secreted virulence factors. As these groups of virulence
factors commonly are oppositely controlled by agr this ob-
servation indicates that the altered expression elicited by
antibiotics is independent of agr. To address this issue
more systematically we examined the expression of
RNAIII, hla and spa for several classes of antibiotics using
an agar-based reporter fusion assay recording the tran-
scriptional activity of the corresponding promoter fusions.
Also we have studied in details, the diverse modulation of
spa transcription by various cephalosporins.
Results and discussion
Antibiotics modulate RNAIII, spa and hla differently
We have used S. aureus strains carrying promoter lacZ
fusions in RNAIII, hla and spa to study the transcriptional
effects of antibiotics on virulence gene expression. Weinvestigated the impact of a wide range of antibiotics in-
cluding cell wall active antibiotics, that are the drug of
choice when treating staphylococcal infections [20]. A disc
diffusion assay was used for a broad screen of modulation
of RNAIII, spa and hla transcription by various types of
antibiotics (see Figure 1 for the cephalosporin representa-
tives). A qualitative measure of gene expression was
obtained by evaluation of the color intensity of the ring
surrounding the inhibition zone (Figure 1). Results are
listed in Table 1. The screen shows that the tested amino-
glycosides reduced transcription of all reporter fusions,
while fluorquinolones stimulated their transcription. On
the other hand, while all β-lactams stimulated transcrip-
tion of RNAIII and hla some enhanced and others
reduced transcription of spa. The differentiated spa regu-
lation was restricted to the cephalosporin group within
the β-lactam family.
Table 1 Disc diffusion assay
Class Group Antibiotics rnaIII spa hla
Aminoglycosides amikacin - - -
kanamycin - - -
gentamycin - - -
spectinomycin - - -
streptomycin - - -
tobramycin - - -
Fluoroquinolones ciprofloxacin, + + +
enfrofloxacin + + +
ß-lactams Penicillins ampicillin + + +
amoxicillin/clavulanic acid + + +
penicillin V + + +
oxacillin + + +
ticarcillin + + +
Cephalosporins cefalotin (1st) + + +
cefamandole (2nd) + + +
cefoxitin (2nd) + + +
cefepime (2nd) + - +
cefuroxime (2nd) + - +
cefotaxime (3rd) + - +
ceftazidime (3rd) + + +
cefixime (3rd) + + +
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Bacterial biofilm formation by S. aureus is a serious
problem especially associated with the pathogenesis of
implantable device-related infections, contributing to
increased morbidity and mortality [21,22]. It is known
that biofilm detachment is controlled by the agr quorum-
sensing system [23-25] and because we observed oppos-
ite modulation of the agr-controlled spa gene when
treated with the closely related antibiotics cefalotin and
cefotaxime, we chose to investigate their influence on
biofilm formation of S. aureus 8325–4. At sub-inhibitory
concentrations both compounds reduced biofilm forma-
tion but the effect was most pronounced in the cefalotin
exposed cultures (Figure 2). In our disc diffusion assay
we observed increased expression of RNAIII when S.
aureus was treated with cefalotin and cefotaxime
(Table 1). Thus, the reduced biofilm formation correlates
with an increased agr activity that previously has been
shown to increase the detachment of S. aureus from
biofilm and reduce biofilm [18,23,25]. The effect of sub-
inhibitory cephalosporins on biofilm formation has been
studied earlier with contradictory effect; here cefalotin
and cephalexin respectively resulted in a denser bio-
films [20,26]. These discrepancies may be explained by
variations in methods used to study biofilm formation.
Also, strain 8325–4 carries a mutation in rsbU thatdiminishes SigB activity [27]. Such strain variation is
quite common in S. aureus and may explain differences
between studies.
Minor structural changes modulate spa differently
In our screen we had observed a differential modulation
of spa expression when exposed to the closely related
cephalosporins, cefalotin and cefotaxim. While both sub-
stances stimulated RNAIII transcription, cefalotin stimu-
lated and cefotaxim repressed transcription of spa. This
result was verified using qRT-PCR (Figure 3). Cefalotin
and cefotaxime are 1st and 2nd generation cephalopspor-
ins, respectively. Subrt et al. (2011) suggested that the
generations of cephalosporines may cause the differences
in spa expression [20]. In accordance with our data,
they also found spa to be strongly stimulated by cefa-
lotin (1st generation) but reduced by cefoperazone
(3rd generation). To address the relationship between
chemical structure, generation and spa expression in more
detail we included additional cephalosporins with only
minor structural differences (results summarized in
Table 1). We tested cefoxitin and cefamandole, two 2nd
generation cefalosporins for their effect on spa regulation
and found them to stimulate spa while cefepime, another
2nd generation cephalosporin, down-regulated spa
(Figure 1). An additional 3rd generation cephalosporin
Figure 3 Effect of cefalotin and cefotaxime on 8325–4 spa and
RNAIII expression using qRT-PCR. Cefalotin and cefotaxime were
used in the concentrations 15.6 ng/ml and 8.3 ng/ml, respectively.
Error bars represent standard deviation of biological replicates, n = 3.
A 
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Figure 2 Biofilm formation by S. aureus 8325–4. A) Absorbance
at 490 nm of 8325–4 and 8325–4 treated with cefotaxime (CTX)
and cefalotin (CEF) respectively. B) Crystal violet staining of
biofilm of 8325–4 and 8325–4 treated with cefotaxime (CTX) and
cefalotin (CEF) respectively.
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that the variable effects of cephalosporins on spa expres-
sion is not linked to the generation of the given cephalo-
sporin but rather to specific structural features of the
compounds. Examination of the chemical structures
revealed that compounds reducing spa transcription,
namely cefepime, cefuroxime and cefotaxime all have a
distinct methyloxime group N-O-CH3, while the
remaining have an acidic substituted oxime group, i.e. N-
O-C(CH3)2CO2H or N-O-CH2-CO2H (Figure 4). These
minor chemical changes could result in different binding
affinities to a receptor molecule, such as the PBPSs. Cefa-
lotin, cefamandole, cefoxitin and ceftazidime which stimu-
lated spa have the greatest affinity for PBP1, PBP4 and
PBP3 respectively [17,28-30] while cefotaxime and cefur-
oxime that down-regulated spa have highest affinity for
PBP2 [29,31]. The observed down-regulation of spa by the
latter two substances coincides with a stimulation of
RNAIII (Table 1) correlating with agr-dependence,
whereas the simultaneous stimulation of RNAIII and spa
transcription by cefalotin, cefoxitin and ceftazidime isremarkable and must be considered agr-independent. In
this study we have shown that the differences in spa tran-
scription regulation are not due to cephalosporin gener-
ation but may be linked to small structural differences
between the compounds. However, further studies are
needed to elucidate the underlying mechanism.
Conclusions
Our study shows that in S. aureus, sub-inhibitory con-
centrations of antibiotics diversely modulate virulence
gene expression and that minor structural changes in
the chemical structure have dramatic influence on their
effect.
Methods
Strains and growth conditions
We used different S. aureus strains carrying lacZ promo-
tor fusions in RNAIII, hla and spa. Before experiments,
strains were incubated on tryptic soy agar (TSA) and
grown overnight at 37°C. For the disc diffusion assay, an
additional overnight incubation at 37°C in tryptic soy
broth (TSB) aerated by shaking was performed. Strains
are listed in Table 2.
Antibiotics, MIC- and sub-MIC determination
Antibiotics used in this study were: aminoglycosides
(amikacin, kanamycin, gentamycin, spectinomycin,
streptomycin, tobramycin), fluoroquinolones (ciprofloxa-
cin, enfrofloxacin), and β-lactams (ampicillin, penicillin,
oxacillin, amoxicillin/clavulanic acid, ticarcillin, cefalotin,
cefepime, cefotaxime, cefuroxime, cefamandole, cefoxi-
tin, ceftazidine, cefixime). Antibiotics were obtained
from Sigma and Antimicrobial Susceptibility Testing
discs (AST disc) from Oxoid Limited.
The minimal inhibitory concentrations (MIC)
values were determined by broth microdilution assay
as recommended by CLSI standards [32]. The sub-
Table 2 S. aureus strains and constructs used in this
study
Strain Relevant characteristics Reference
8325-4 Wild-type strain cured of known prophages [33]
JLA341 SH1000 agr (RNA III)::pAZ106 agr+ [34]
PC203 spa+ spa::lacZ EyR [35]
PC322 hla+ hla::lacZ EyR [35]
Cephalosporin  Structure 
Cefalotin 
Cefoxitin 
Cefamandole 
Cefepime 
Cefuroxime 
Cefotaxime 
Ceftazidime 
Figure 4 Chemical structures of the Cephalosporins applied in
this study. The acidic functional group is circled in red, while the
blue circled groups end in a space filling neutral group.
Table 3 Primers used in this study
Primer name Sequence References
rnaIII-F GCACTGAGTCCAAGGAAACTAAC This study
rnaIII- R AAGCCATCCCAACTTAATAACC This study
spa-F CAAACGGCACTACTGCTGAC This study
spa-R CATGGTTTGCTGGTTGCTTC This study
pyk-F AGGTTGAACTCCCCAAACAA This study
pyk-R GCAGCCCAAGATTACAAAAA This study
(+) up regulation, (−) down regulation of the given promoter::lacZ fusion.
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meyer flasks using OD600 to monitor growth of
S. aureus 8325-4 [33]. A 2-fold serial dilution starting
with the MIC value as the highest concentration wasapplied for every antibiotic. The highest concentration of
a given antibiotic that did not visibly inhibit growth was
chosen as the individual sub-inhibitory concentration.
MIC values for cefalotin and cefotaxime were 10 μg/ml
and 0.5 μg/ml respectively while the sub-inhibitory con-
centrations were 15.6 ng/ml and 8.3 ng/ml, respectively.Disc diffusion assay
Overnight cultures containing the transcriptional lacZ
promoter fusions [34,35] were adjusted to OD600 =
0.0035 in 0.9% NaCl. One ml of the culture was placed
in a petri-dish and mixed with 25 ml of 50°C warm TSA
supplemented with Erythromycin (5 μg/ml) and X-gal
(150 μg/ml). After solidification AST discs were placed
on top of the plates and they were incubated for 16 hours
at 37°C. Changes in gene expression were evaluated by
visually judging the intensity of the blue color close to
the inhibition zone compared to the background.Quantitative reverse transcriptase PCR
The effects of sub-inhibitory antibiotic exposure on gene
expression was confirmed using quantitative reverse
transcriptase PCR (qRT-PCR). Cefalotin and cefotaxime
were used in the concentrations 15.6 ng/ml and 8.3 ng/ml,
respectively. S. aureus 8325–4 was grown to OD600 = 1.0
and RNA purification was done using Qiagen RNeasy
mini-prep according to the protocol. The RNA samples
were further treated with DNase (Fermentas) before
cDNA was made with a RT kit from Applied Biosys-
tems. qRT-PCR was carried out in 96-well microtitre
PCR plates (Sarstedt) using the primers listed in Table 3.
The housekeeping pyruvate kinase (pyk) was used for
normalization.
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Relevant strains were grown to OD600 0.2 at conditions
and antibiotic concentrations as described above. Hun-
dred μl pre-culture was added to a 96-well microtiter
plate (Sarstedt) and incubated overnight at 37°C. Then,
each well was washed three times with 200 μl physio-
logical saline and stained with 0.1% crystal violet for
30 min. The crystal violet was washed out and each
well washed three times with water. The amount of bio-
film was determined by spectrophotometer at 490 nm
after dissolving the crystal violet with 96% ethanol for
30 min. The test samples were made in triplicate and
the experiment repeated three times.
Competing interests
The authors declare that they have no competing interests.
Authors’ contributions
LN was the primary author of the manuscript, a part of the disc assay screen,
qPCR and biofilm assay. MR performed minimum inhibition concentration
determination and the majority of disc assay screen. DI participated in
analyzing the chemical structures. HI and JH designed the study. All authors
contributed in writing and reviewing the manuscript. All authors read and
approved the final manuscript.
Acknowledgement
The research was supported by the Danish Council for Independent
Research (# 274-08-0531) and the Lundbeck foundation.
Received: 29 May 2012 Accepted: 19 August 2012
Published: 25 August 2012
References
1. Davies J: Everything depends on everything else. Clin Microbiol Infect
2009, 15(Suppl 1):1–4. doi:10.1111/j.1469-0691.2008.02682.x. CLM2682 [pii].
2. Kummerer K: The presence of pharmaceuticals in the environment due
to human use–present knowledge and future challenges. J Environ
Manage 2009, 90:2354–2366. doi:10.1016/j.jenvman.2009.01.023. S0301-4797
(09)00022-X [pii].
3. Goh EB, Yim G, Tsui W, McClure J, Surette MG, Davies J: Transcriptional
modulation of bacterial gene expression by subinhibitory concentrations
of antibiotics. Proc Natl Acad Sci U S A 2002, 99:17025–17030. doi:10.1073/
pnas.252607699. 252607699 [pii].
4. Ohlsen K, Ziebuhr W, Koller KP, Hell W, Wichelhaus TA, Hacker J: Effects of
subinhibitory concentrations of antibiotics on alpha-toxin (hla) gene
expression of methicillin-sensitive and methicillin-resistant
Staphylococcus aureus isolates. Antimicrob Agents Chemother 1998,
42:2817–2823.
5. Walsh C: Molecular mechanisms that confer antibacterial drug resistance.
Nature 2000, 406:775–781. doi:10.1038/35021219.
6. Lowy FD: Staphylococcus aureus infections. N Engl J Med 1998, 339:520–532.
doi:10.1056/NEJM199808203390806.
7. Otto M: Staphylococcal biofilms. Curr Top Microbiol Immunol 2008,
322:207–228.
8. Bhakdi S, Tranum-Jensen J: Alpha-toxin of Staphylococcus aureus.
Microbiol Rev 1991, 55:733–751.
9. Walev I, Martin E, Jonas D, Mohamadzadeh M, Muller-Klieser W, Kunz L,
Bhakdi S: Staphylococcal alpha-toxin kills human keratinocytes by
permeabilizing the plasma membrane for monovalent ions. Infect Immun
1993, 61:4972–4979.
10. Gomez MI, Lee A, Reddy B, Muir A, Soong G, Pitt A, Cheung A, Prince A:
Staphylococcus aureus protein A induces airway epithelial inflammatory
responses by activating TNFR1. Nat. Med. 2004, 10:842–848. doi:10.1038/
nm1079. nm1079 [pii].
11. Palmqvist N, Foster T, Tarkowski A, Josefsson E: Protein A is a virulence
factor in Staphylococcus aureus arthritis and septic death. Microb Pathog
2002, 33:239–249. S0882401002905334 [pii].12. Labandeira-Rey M, Couzon F, Boisset S, Brown EL, Bes M, Benito Y, Barbu EM,
Vazquez V, Hook M, Etienne J, Vandenesch F, Bowden MG:
Staphylococcus aureus Panton-Valentine leukocidin causes necrotizing
pneumonia. Science 2007, 315:1130–1133. doi:10.1126/science.1137165.
1137165 [pii].
13. George EA, Muir TW: Molecular mechanisms of agr quorum sensing in
virulent staphylococci. ChemBioChem 2007, 8:847–855. doi:10.1002/
cbic.200700023.
14. Novick RP: Autoinduction and signal transduction in the regulation of
staphylococcal virulence. Mol Microbiol 2003, 48:1429–1449. 3526 [pii].
15. Novick RP, Geisinger E: Quorum sensing in staphylococci. Annu Rev Genet
2008, 42:541–564. doi:10.1146/annurev.genet.42.110807.091640.
16. Novick RP, Ross HF, Projan SJ, Kornblum J, Kreiswirth B, Moghazeh S:
Synthesis of staphylococcal virulence factors is controlled by a
regulatory RNA molecule. EMBO J 1993, 12:3967–3975.
17. Georgopapadakou NH, Smith SA, Bonner DP: Penicillin-binding proteins in
a Staphylococcus aureus strain resistant to specific beta-lactam
antibiotics. Antimicrob Agents Chemother 1982, 22:172–175.
18. Horswill AR, Nauseef WM: Host interception of bacterial communication
signals. Cell Host. Microbe 2008, 4:507–509. doi:10.1016/j.chom.2008.11.003.
S1931-3128(08)00370-3 [pii].
19. Kuroda H, Kuroda M, Cui L, Hiramatsu K: Subinhibitory concentrations of
beta-lactam induce haemolytic activity in Staphylococcus aureus
through the SaeRS two-component system. FEMS Microbiol Lett 2007,
268:98–105. doi:10.1111/j.1574-6968.2006.00568.x. FML568 [pii].
20. Subrt N, Mesak LR, Davies J: Modulation of virulence gene expression by
cell wall active antibiotics in Staphylococcus aureus. J Antimicrob
Chemother 2011, 66:979–984. doi:10.1093/jac/dkr043. dkr043 [pii].
21. Bahna P, Dvorak T, Hanna H, Yasko AW, Hachem R, Raad I:
Orthopaedic metal devices coated with a novel antiseptic dye for
the prevention of bacterial infections. Int J Antimicrob Agents 2007,
29:593–596. doi:10.1016/j.ijantimicag.2006.12.013. S0924-8579(07)
00028-3 [pii].
22. Stefani S, Goglio A: Methicillin-resistant Staphylococcus aureus: related
infections and antibiotic resistance. Int J Infect Dis 2010, 14(Suppl 4):S19–S22.
doi:10.1016/j.ijid.2010.05.009. S1201-9712(10)02367-2 [pii].
23. Boles BR, Horswill AR: Agr-mediated dispersal of Staphylococcus
aureus biofilms. PLoS.Pathog 2008, 4:e1000052. 10.1371/journal.
ppat.1000052 [doi].
24. Vuong C, Saenz HL, Gotz F, Otto M: Impact of the agr quorum-sensing
system on adherence to polystyrene in Staphylococcus aureus. J Infect
Dis 2000, 182:1688–1693. doi:10.1086/317606. JID000516 [pii].
25. Yarwood JM, Bartels DJ, Volper EM, Greenberg EP: Quorum sensing in
Staphylococcus aureus biofilms. J Bacteriol 2004, 186:1838–1850.
26. Haddadin RN, Saleh S, Al-Adham IS, Buultjens TE, Collier PJ: The
effect of subminimal inhibitory concentrations of antibiotics on
virulence factors expressed by Staphylococcus aureus biofilms.
J Appl Microbiol 2010, 108:1281–1291. doi:10.1111/j.1365-
2672.2009.04529.x. JAM4529 [pii].
27. Giachino P, Engelmann S, Bischoff M: Sigma(B) activity depends on RsbU
in Staphylococcus aureus. J Bacteriol 2001, 183:1843–1852. doi:10.1128/
JB.183.6.1843-1852.2001.
28. Georgopapadakou NH, Liu FY: Binding of beta-lactam antibiotics to
penicillin-binding proteins of Staphylococcus aureus and Streptococcus
faecalis: relation to antibacterial activity. Antimicrob Agents Chemother
1980, 18:834–836.
29. Neu HC: Relation of Structural Properties of Beta-lactam Antibiotics to
Anticacterial Activity. Am J Med 1985, 79. Ref Type: Generic.
30. Stone GW, Zhang Q, Castillo R, Doppalapudi VR, Bueno AR, Lee JY, Li Q,
Sergeeva M, Khambatta G, Georgopapadakou NH: Mechanism of action
of NB2001 and NB2030, novel antibacterial agents activated by beta-
lactamases. Antimicrob Agents Chemother 2004, 48:477–483.
31. Georgopapadakou NH, Dix BA, Mauriz YR: Possible physiological functions
of penicillin-binding proteins in Staphylococcus aureus. Antimicrob Agents
Chemother 1986, 29:333–336.
32. Clinical and Laboratory Standards Instutute: Performance Standards for
Antimicrobial Susceptibility Testing. M100-S15, CLSI, Wayne, PA, USA: Fifteenth
Informational Supplement; 2005. Ref Type: Generic.
33. Novick R: Properties of a cryptic high-frequency transducing phage in
Staphylococcus aureus. Virology 1967, 33:155–166. 0042-6822(67)
90105-5 [pii].
Nielsen et al. BMC Research Notes 2012, 5:457 Page 7 of 7
http://www.biomedcentral.com/1756-0500/5/45734. Horsburgh MJ, Aish JL, White IJ, Shaw L, Lithgow JK, Foster SJ: sigmaB
modulates virulence determinant expression and stress resistance:
characterization of a functional rsbU strain derived from Staphylococcus
aureus 8325–4. J Bacteriol 2002, 184:5457–5467.
35. Chan PF, Foster SJ: The role of environmental factors in the regulation of
virulence-determinant expression in Staphylococcus aureus 8325–4.
Microbiology 1998, 144(Pt 9):2469–2479.
doi:10.1186/1756-0500-5-457
Cite this article as: Nielsen et al.: Diverse modulation of spa transcription
by cell wall active antibiotics in Staphylococcus aureus. BMC Research
Notes 2012 5:457.Submit your next manuscript to BioMed Central
and take full advantage of: 
• Convenient online submission
• Thorough peer review
• No space constraints or color ﬁgure charges
• Immediate publication on acceptance
• Inclusion in PubMed, CAS, Scopus and Google Scholar
• Research which is freely available for redistribution
Submit your manuscript at 
www.biomedcentral.com/submit
